MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 104 filers reported holding MERUS N V in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,182,000 | -66.1% | 59,000 | -61.7% | 0.51% | -73.8% |
| Q2 2022 | $3,487,000 | -44.0% | 154,000 | -34.6% | 1.94% | -33.2% |
| Q1 2022 | $6,227,000 | -16.9% | 235,500 | 0.0% | 2.91% | -7.6% |
| Q4 2021 | $7,489,000 | +179.0% | 235,500 | +93.0% | 3.15% | +232.4% |
| Q3 2021 | $2,684,000 | -63.7% | 122,000 | -73.5% | 0.95% | -55.7% |
| Q2 2020 | $7,401,000 | +499.8% | 460,000 | +564.0% | 2.14% | +140.0% |
| Q3 2019 | $1,234,000 | – | 69,274 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |